These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8082527)

  • 1. Plasma endothelin in NIDDM patients with and without complications.
    Bertello P; Veglio F; Pinna G; Gurioli L; Molino P; Alban S; Chiandussi L
    Diabetes Care; 1994 Jun; 17(6):574-7. PubMed ID: 8082527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria.
    Lee YJ; Shin SJ; Tsai JH
    Diabetes Care; 1994 Apr; 17(4):263-6. PubMed ID: 8026280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy.
    Kamoi K; Ishibashi M; Yamaji T
    Diabetes Res Clin Pract; 1994 Jul; 24(3):125-9. PubMed ID: 7988343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between the plasma levels of endothelin and angiopathy in diabetic patients].
    Zeng ZP; Tang D; Sun ML
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):467-9. PubMed ID: 7867443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Groop L; Ekstrand A; Forsblom C; Widén E; Groop PH; Teppo AM; Eriksson J
    Diabetologia; 1993 Jul; 36(7):642-7. PubMed ID: 8359582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs.
    Mangiafico RA; Malatino LS; Santonocito M; Spada RS
    Int Angiol; 1998 Jun; 17(2):97-102. PubMed ID: 9754897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects.
    Chaiken RL; Khawaja R; Bard M; Eckert-Norton M; Banerji MA; Lebovitz HE
    Diabetes Care; 1997 May; 20(5):709-13. PubMed ID: 9135931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM.
    Niskanen LK; Penttilã I; Parviainen M; Uusitupa MI
    Diabetes Care; 1996 May; 19(5):486-93. PubMed ID: 8732714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
    Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
    Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria is closely related to diabetic macroangiopathy.
    Sasaki A; Oikawa S; Toyota T
    Diabetes Res Clin Pract; 1999 Apr; 44(1):35-40. PubMed ID: 10414938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients.
    Bruno CM; Meli S; Marcinno M; Ierna D; Sciacca C; Neri S
    J Biol Regul Homeost Agents; 2002; 16(2):114-7. PubMed ID: 12144123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients.
    Perfetto F; Tarquini R; de Leonardis V; Piluso A; Lombardi V; Tarquini B
    Acta Diabetol; 1995 Dec; 32(4):263-7. PubMed ID: 8750766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular ions in NIDDM: relation of calcium to hyperglycemia and cardiac mass.
    Barbagallo M; Gupta RK; Resnick LM
    Diabetes Care; 1996 Dec; 19(12):1393-8. PubMed ID: 8941470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular damage and not hypertension per se influences endothelin-1 plasma levels in patients with non insulin dependent diabetes mellitus.
    Perfetto F; Tarquini R; de Leonardis V; Piluso A; Becucci A; Anselmi B; Curradi C; Tapparini L; Tarquini B
    Recenti Prog Med; 1997; 88(7-8):317-20. PubMed ID: 9270291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endothelin levels in NIDDM patients with macroangiopathy.
    Donatelli M; Colletti I; Bucalo ML; Russo V; Verga S
    Diabetes Res; 1994; 25(4):159-64. PubMed ID: 7648786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma endothelin-1 levels in patients with diabetes mellitus with or without vascular complication.
    Kanno K; Hirata Y; Shichiri M; Marumo F
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S475-6. PubMed ID: 1725417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria.
    Kodama T; Tomiyama T; Ishizaki T; Baba T
    J Diabetes Complications; 1992; 6(2):70-6. PubMed ID: 1611142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes.
    Goldschmid MG; Domin WS; Ziemer DC; Gallina DL; Phillips LS
    Diabetes Care; 1995 Jul; 18(7):955-61. PubMed ID: 7555556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipoprotein(a) is increased in hypertensive NIDDM patients.
    Hancu N; Netea MG; Iancu S
    Diabetes Care; 1995 Jun; 18(6):879-80. PubMed ID: 7555518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.